Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference
Rhea-AI Summary
Progyny (Nasdaq: PGNY) announced that CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 3:30 p.m. ET. Live audiocasts and replays will be accessible via the Events and Presentations section of Progyny’s investor relations website.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 23 | Earnings scheduling | Neutral | -2.1% | Announced timing and conference-call details for second-quarter 2026 results |
| May 28 | Member survey | Positive | +0.8% | Survey showed demand for personalized guidance across fertility and women’s health |
| May 26 | Share repurchase | Positive | +0.7% | Board authorized up to $200 million of common-stock buybacks |
| May 11 | Conference presentation | Neutral | -4.9% | Announced CEO and CFO participation in a healthcare conference fireside chat |
| May 07 | Q1 earnings | Positive | +23.8% | Reported record first-quarter revenue, profit and adjusted EBITDA |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Historical reactions were positive after the share-repurchase and Q1 earnings announcements, but negative after the prior conference-presentation notice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that its CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 3:30 p.m. ET.
Live audiocasts and replays of the webcasted session will be available in the Events and Presentations section of Progyny’s investor relations website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women's health and family building solutions, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive and intentionally designed solutions simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, INC. 5000, INC. Power Partners and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com